January 8, 2020 – RSIP Vision has launched a new artificial intelligence (AI) ultrasound module that enables fast and accurate point-of-care heart evaluations. This includes onsite diagnostic from the parasternal long axis (PLAX) view. This new vendor-neutral technology will be available to third-party ultrasound manufacturers and medical devices vendors.

January 6, 2020 — A new Weill Cornell Medicine found the risk of dying seven years after coronary artery bypass graft (CABG) surgery was significantly lower in men receiving multiple bypass grafts rather than single grafts. The study also looked at CABG in women and there was no apparent difference between single or multiple vessel bypass procedures, but overall women had a higher mortality rate. The study published online Dec.

January 6, 2021 — Smoking traditional cigarettes in addition to using e-cigarettes results in harmful health effects similar to smoking cigarettes exclusively, according to new research published today in the American Heart Association (AHA) flagship journal Circulation.[1]

January 6, 2021 — The U.S. Food and Drug Administration (FDA) has granted the designation of breakthrough device to P+F Products + Features GmbH TricValve Transcatheter Bicval Valves System.  

January 6, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Ultromics' EchoGo Pro, an artificial intelligence (AI) powered, outcomes-driven, decision support tool to automatically identify coronary artery disease (CAD) in echocardiograms. 

Houston Aortic Symposium: Frontiers in Cardiovascular Diseases

The most popular DAIC content in December 2020 included the Boston Scientific Lotus TAVR valve being taken off the market, CMS approving expanding coverage of LVADs for more Medicare patients and numerous COVID-19 related cardiology stories and videos.

January 5, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of December 2020. This is based on the website’s record 550,357 pageviews for the month. 

1. Image Gallery Showing Impact of the COVID-19 Pandemic

There was much fanfare over the U.S. Food and Drug Administration (FDA) emergency use authorizations (EUAs) in December for the Pfizer and Moderna COVID-19 (SARS-CoV-2) vaccines. However, the vaccination program to date has fallen very far short the promises made by the government when the first vaccine was approved, with less than one quarter of the promised vaccine being delivered.

The Centers for Disease Control and Prevention (CDC) Dec. 3, released an interim guidance document  to federal, state, and local jurisdictions on the allocation of initial doses of the COVID-19 vaccines. The document outlines who qualified for the first round of vaccinations with the Pfizer and Moderna vaccines. The priority order is given based on who is most at risk, those who are directly exposed to COVID carriers or patients on a daily bases and essential workers.

December 29, 2020 — Edwards Lifesciences announced Dec. 21 that the first patient was treated in the RESTORE clinical trial, which is evaluating the safety and effectiveness of the investigational Harpoon Beating Heart Mitral Valve Repair System in the United States and Canada. 

The Harpoon transcatheter mitral valve repair (TMVR) system uses a less-invasive technique than open-heart surgery in order to treat severe degenerative mitral valve regurgitation. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now